MyD88 contributes to neuroinflammatory responses induced by cerebral ischemia/reperfusion in mice
Journal Article
·
· Biochemical and Biophysical Research Communications
- Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002 (China)
- Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA (United States)
- Department of Human Anatomy, Histology and Embryology, Shenyang Medical College, Shenyang, 110000 (China)
Myeloid differentiation primary-response protein-88 (MyD88) is one of adaptor proteins mediating Toll-like receptors (TLRs) signaling. Activation of MyD88 results in the activation of nuclear factor kappa B (NFκB) and the increase of inflammatory responses. Evidences have demonstrated that TLRs signaling contributes to cerebral ischemia/reperfusion (I/R) injury. However, the role of MyD88 in this mechanism of action is disputed and needs to be clarified. In the present study, in a mouse model of cerebral I/R, we examined the activities of NFκB and interferon factor-3 (IRF3), and the inflammatory responses in ischemic brain tissue using ELISA, Western blots, and real-time PCR. Neurological function and cerebral infarct size were also evaluated 24 h after cerebral I/R. Our results showed that NFκB activity increased in ischemic brains, but IRF3 was not activated after cerebral I/R, in wild-type (WT) mice. MyD88 deficit inhibited the activation of NFκB, and the expression of interleukin-1β (IL-1β), IL-6, Beclin-1 (BECN1), pellino-1, and cyclooxygenase-2 (COX-2) increased by cerebral I/R compared with WT mice. Interestingly, the expression of interferon Beta 1 (INFB1) and vascular endothelial growth factor (VEGF) increased in MyD88 KO mice. Unexpectedly, although the neurological function improved in the MyD88 knockout (KO) mice, the deficit of MyD88 failed to reduce cerebral infarct size compared to WT mice. We concluded that MyD88-dependent signaling contributes to the inflammatory responses induced by cerebral I/R. MyD88 deficit may inhibit the increased inflammatory response and increase neuroprotective signaling. - Highlights: • Cerebral ischemia/reperfusion activates inflammatory responses in brain tissue. • MyD88-dependent pathway contributes to the activated inflammatory responses. • MyD88 deficit increases neuroprotective signaling in ischemic brain.
- OSTI ID:
- 22696679
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 1 Vol. 480; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
The TRIF-dependent signaling pathway is not required for acute cerebral ischemia/reperfusion injury in mice
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice
The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia/reperfusion injury by attenuating the pro-inflammatory response
Journal Article
·
Thu Dec 17 23:00:00 EST 2009
· Biochemical and Biophysical Research Communications
·
OSTI ID:22199916
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice
Journal Article
·
Thu Nov 19 23:00:00 EST 2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:22592806
The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia/reperfusion injury by attenuating the pro-inflammatory response
Journal Article
·
Fri Mar 25 00:00:00 EDT 2016
· Biochemical and Biophysical Research Communications
·
OSTI ID:22596309